https://doi.org/10.1038/s41591-018-0078-7
D
David Gyorki
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
263
Papers
7.8K
Citations
35
h-index
92
i10-index
David Gyorki is an academic researcher from University of Melbourne. The author has contributed to research in topics: Cutaneous Melanoma Detection and Management & CAR-T cell therapy research & Sarcoma Diagnosis and Treatment. The author has an h-index of 35, co-authored 224 publications.
ORCID: 0000-0002-3165-4694Papers by this author
worksSingle-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
2018 · Nature Medicine · 971 citations
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
2017 · Journal of Clinical Investigation · 310 citations
https://doi.org/10.1172/jci89455
Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries
2021 · The Lancet · 288 citations
https://doi.org/10.1016/s0140-6736(21)00001-5
Systemic Therapy for Melanoma: ASCO Guideline Update
2023 · Journal of Clinical Oncology · 175 citations
https://doi.org/10.1200/jco.23.01136
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma
2018 · Scientific Reports · 126 citations
https://doi.org/10.1038/s41598-018-28944-3
Resident macrophages influence stem cell activity in the mammary gland
2009 · Breast Cancer Research · 120 citations
https://doi.org/10.1186/bcr2353
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat